Abstract
Various approaches to eliminate transfusion-associated cytomegalovirus (TA-CMV) infection in neonates have been attempted. TA-CMV in neonates has been prevented by using frozen, deglycerolized red blood cells [1, 2]. The use of saline-washed red blood cells has been shown to be effective in reducing TA-CMV in one study [3] but ineffective in another [4], Serological screening to provide CMV-seronegative blood has been shown to be an effective method of prevention in several studies [5, 6] and has the advantage of applicability to all types of blood products. Donor populations, however, vary considerably in their seropositivity rates, a situation thus limiting the available supply of seronegative blood in some areas [7, 8].
Original language | English (US) |
---|---|
Pages (from-to) | 820-822 |
Number of pages | 3 |
Journal | Journal of Infectious Diseases |
Volume | 157 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1988 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine